Researchers from Australia will join forces with colleagues at the Arizona Cancer Center to jointly develop skin cancer prevention and treatment strategies.
Michael A. Bookman, MD, section chief of Hematology/Oncology at the Arizona Cancer Center, has been appointed to chair the Ovarian Committee of the Gynecologic Oncology Group (GOG).
Thomas Doetschman, PhD, and Tomislav Dragovich, MD, PhD, have been named co-leaders of the Arizona Cancer Center’s Gastrointestinal Cancer research program.
Emmanuelle J. Meuillet, PhD, aims to understand the role of inflammation in colon carcinogenesis and to develop a novel targeted therapy to treat it. A five-year, $1,784,878 grant from the National Cancer Institute will fund her research.
The community is invited to the pink carpet premiere of Woman to Woman: Let’s Talk about Breast Cancer / Mujer a Mujer: Una Conversación Sobre Cáncer de Seno, a documentary funded by the Susan G. Komen for the Cure of Southern Arizona. Both premieres, the Spanish version on Aug. 28 and the English version on Oct. 30, will be held at 2 p.m. in DuVal Auditorium at University Medical Center, 1501 N. Campbell Ave. The premieres are free and open to the public.
Joyce A. Schroeder, PhD, an Arizona Cancer Center member, has been awarded a US patent for a first-in-class breast cancer treatment.
The University of Arizona Cancer Center is opening a study of a drug that may help prevent breast cancer in postmenopausal women who are at risk for developing breast cancer.
Arizona Cancer Center researcher receives $1.8 million to develop novel colon cancer targeted therapy
The National Cancer Institute has awarded a five-year, $1,784,878 grant to an Arizona Cancer Center researcher to study the role of inflammation in colon carcinogenesis and to develop a new targeted therapy to treat colon cancer.
A synthetic hormone developed at the University of Arizona has been shown to offer relief for a rare skin disease in international clinical studies.
Arizona Cancer Center physicians Margaret Miller, MD, and Thomas Miller, MD, will participate in the 15th annual North American Educational Forum on Lymphoma in September.